The Valley REN is delighted to share this great business news for the Annapolis Valley region.
A five-year expansion announced today by BioVectra Inc. is expected to bring 110 highly skilled, full-time jobs to the Windsor (Nova Scotia) plant of the Atlantic Canadian pharmaceutical company.
BioVectra, based in Charlottetown, PEI, announced the $144.6-million expansion today. A further 40 jobs are expected to be created at the Charlottetown regional headquarters. The project includes a $37.5-million federal contribution announced today by Prime Minister Justin Trudeau.
More than 50 people are currently employed at the Windsor site, which is a late-stage to commercial-scale microbial fermentation and complex chemistry facility.
BioVectra’s Windsor General Manager, Heather Delage, who serves on the Valley REN board, said the expansion will “propel us toward being a top-tier player in the biologics field, where many therapies are advancing rapidly, and changing the way healthcare is delivered.”
Valley REN acting CEO Jennifer Tufts welcomed the news, saying “BioVectra’s commitment to growing their global business in the Valley showcases our skilled workforce and lifestyle attraction for employees.
“The 110 new jobs on the horizon show our youth that they can pursue a rewarding, well-paying career in complex manufacturing in the Annapolis Valley,” said Tufts.
BioVectra has a global client base that includes most of the top 20 biopharmaceutical companies in the world. It is part of the Mallinckrodt Pharmaceuticals company that has its global headquarters in the U.K.
You can read the company’s media release here.
As research analyst for the Valley REN, Rachel Brighton brings 25 years’ experience as a journalist, editor, publisher, manager, consultant and not-for-profit director in Canada and Australia.